IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Un-audited ....
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals & Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Tuesday, 11 November 2025 to consider and approve the unaudited financial results for the quarter and half year ended 30 September 2025 (Q2 FY26 and H1 FY26). The trading window for designated persons, which closed on 1 October 2025, will remain shut until 48 hours after the results are declared and reopen on 14 November 2025. This is a routine regulatory filing under SEBI LODR Regulation 29 ahead of the quarterly earnings announcement. No financial figures, guidance, or projections are included in this notice.
This is a procedural intimation and has no direct impact on the stock. Investors should watch for the actual Q2/H1 FY26 results on or after 11 November 2025 for any material data on revenue, margins, and profitability.